Fibrinogen levels linked to improved survival in bleeding patients

A critical study found that pre-treatment fibrinogen levels below 1.3 g/l indicate poor prognosis in patients with major bleeding. Among 7,063 patients analyzed, those with fibrinogen above this threshold experienced a significant survival benefit after 28 days. Furthermore, a post-treatment fibrinogen target of 2.0-2.5 g/l was identified as optimal for enhancing survival rates. These findings suggest the importance of monitoring and managing fibrinogen levels in critically bleeding patients to improve ICU outcomes.